144 related articles for article (PubMed ID: 6172171)
1. Ploidy and proliferative characteristics in monoclonal gammopathies.
Latreille J; Barlogie B; Johnston D; Drewinko B; Alexanian R
Blood; 1982 Jan; 59(1):43-51. PubMed ID: 6172171
[TBL] [Abstract][Full Text] [Related]
2. Lack of correlation between plasma cell thymidine labelling index and serum beta-2-microglobulin in monoclonal gammopathies.
Boccadoro M; Durie BG; Frutiger Y; Gavarotti P; Redoglia V; Massaia M; D'Alberto M; Marmont F; Gallamini A; Tribalto M
Acta Haematol; 1987; 78(4):239-42. PubMed ID: 3122489
[TBL] [Abstract][Full Text] [Related]
3. Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy.
Boccadoro M; Gavarotti P; Fossati G; Pileri A; Marmont F; Neretto G; Gallamini A; Volta C; Tribalto M; Testa MG
Br J Haematol; 1984 Dec; 58(4):689-96. PubMed ID: 6518137
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle analysis of Waldenstrom's macroglobulinemia.
Ocio EM; Mateo G; Vidriales B; Lopez-Berges MC; Garcia-Sanz R; Hernandez JM; Orfao A; San Miguel JF
Clin Lymphoma; 2005 Mar; 5(4):250-2. PubMed ID: 15794858
[TBL] [Abstract][Full Text] [Related]
5. Determination of the growth fraction in monoclonal gammopathy with the monoclonal antibody Ki-67.
Lokhorst HM; Boom SE; Terpstra W; Roholl P; Gerdes J; Bast BJ
Br J Haematol; 1988 Aug; 69(4):477-81. PubMed ID: 3044442
[TBL] [Abstract][Full Text] [Related]
6. Plasma cell proliferation in monoclonal gammopathies: measurement using BU-1 antibody in flow cytometry and microscopy: comparison with serum thymidine kinase.
Schambeck CM; Wick M; Bartl R; Lamerz R; Fateh-Moghadam A
J Clin Pathol; 1995 May; 48(5):477-81. PubMed ID: 7629298
[TBL] [Abstract][Full Text] [Related]
7. Plasma cell DNA content in multiple myeloma and related paraproteinemic disorders. Relationship with clinical and cytokinetic features.
Montecucco C; Riccardi A; Merlini G; Mazzini G; Giordano P; Danova M; Ascari E
Eur J Cancer Clin Oncol; 1984 Jan; 20(1):81-90. PubMed ID: 6537918
[TBL] [Abstract][Full Text] [Related]
8. Ocular manifestations of multiple myeloma, Waldenström's macroglobulinemia and benign monoclonal gammopathy.
Orellana J; Friedman AH
Surv Ophthalmol; 1981; 26(3):157-69. PubMed ID: 6801795
[TBL] [Abstract][Full Text] [Related]
9. Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma.
Wuilleme S; Robillard N; Lodé L; Magrangeas F; Beris H; Harousseau JL; Proffitt J; Minvielle S; Avet-Loiseau H;
Leukemia; 2005 Feb; 19(2):275-8. PubMed ID: 15538401
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow percentage of plasma cells in the staging of monoclonal gammopathies.
Vercelli D; Di Guglielmo R; Guidi G; Scolari L; Buricchi L; Cozzolino F
Nouv Rev Fr Hematol (1978); 1980; 22(2):139-45. PubMed ID: 7422542
[TBL] [Abstract][Full Text] [Related]
11. Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma.
Greipp PR; Kyle RA
Blood; 1983 Jul; 62(1):166-71. PubMed ID: 6407546
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
Lima M; Teixeira Mdos A; Fonseca S; Gonçalves C; Guerra M; Queirós ML; Santos AH; Coutinho A; Pinho L; Marques L; Cunha M; Ribeiro P; Xavier L; Vieira H; Pinto P; Justiça B
Blood Cells Mol Dis; 2000 Dec; 26(6):634-45. PubMed ID: 11358356
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma: clinical implications.
Bunn PA; Krasnow S; Makuch RW; Schlam ML; Schechter GP
Blood; 1982 Mar; 59(3):528-35. PubMed ID: 6800416
[TBL] [Abstract][Full Text] [Related]
14. The flow-cytometric DNA content of the plasma cells of patients with multiple myeloma is a prognostic factor: a single institution experience.
López-Otero A; Ruiz-Delgado GJ; Hernández-Arizpe A; Ruiz-Argüelles A; Ruiz-Argüelles GJ
Hematology; 2010 Dec; 15(6):378-81. PubMed ID: 21114899
[TBL] [Abstract][Full Text] [Related]
15. [Contribution of bone biopsy with histomorphometry in the evaluation of monoclonal gammopathy].
Alexandre C; Bataille R; Chappard D; Dessauw P; Sany J; Riffat G
Rev Rhum Mal Osteoartic; 1987 Nov; 54(11):717-21. PubMed ID: 3423714
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric DNA analysis and clinical correlations in multiple myeloma.
Tienhaara A; Pelliniemi TT
Am J Clin Pathol; 1992 Mar; 97(3):322-30. PubMed ID: 1543155
[TBL] [Abstract][Full Text] [Related]
17. Marrow cytometry and prognosis in myeloma.
Barlogie B; Alexanian R; Gehan EA; Smallwood L; Smith T; Drewinko B
J Clin Invest; 1983 Sep; 72(3):853-61. PubMed ID: 6193144
[TBL] [Abstract][Full Text] [Related]
18. Genetic propensity to benignity in monoclonal-gammopathy.
Youinou P
Acta Haematol; 1979; 62(3):173-5. PubMed ID: 118617
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal gammopathies of undetermined significance].
Hofmann V
Schweiz Med Wochenschr; 1982 Nov; 112(48):1718-23. PubMed ID: 6817412
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric determination of ploidy and proliferative activity on isolated bone marrow particles and on total bone marrow aspirate.
Ucci G; Mazzini G; Caporali R; Danova M; Montecucco CM; Riccardi A
Basic Appl Histochem; 1987; 31(1):83-90. PubMed ID: 3593175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
